Evidence map›Paper›PMID 29109158›Full record

ArticleAntimicrobial agents and chemotherapy2018

Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.

Stewart G Gardner, Darrell D Marshall, Robert S Daum, Robert Powers, Greg A Somerville

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Adaptive laboratory evolution and independent component analysis disentangle complex vancomycin adaptation trajectories.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Article
  17. Antibiotic resistance: Time of synthesis in a post-genomic age.Computational and structural biotechnology journal · 2021
    Review
  18. Article
  19. Article
  20. Fourier transform infrared spectroscopy: unlocking fundamentals and prospects for bacterial strain typing.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stewart G Gardner *School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Darrell D Marshall *Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Robert S DaumDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Robert PowersDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA rpowers3@unl.edu gsomerville3@unl.edu.
Greg A SomervilleSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, USA rpowers3@unl.edu gsomerville3@unl.edu.
University of Nebraska–Lincoln · USUniversity of Maryland, Baltimore · US

Funding

Targeted mass spectrometry approaches to understand CART processing and recepter interactionsP20GM113126 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GUO, JIANTAO · 2016 to 2025
$20.8M
Redox Biology CenterP30GM103335 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI BECKER, DONALD F · 2012 to 2016
$4.3M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR015468 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI PAUL, PREM S · 2000 to 2000
$2.0M
NCRR NIH HHS C06 RR015468NIGMS NIH HHS P20 GM113126NIGMS NIH HHS P30 GM103335
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptation, PhysiologicalAnti-Bacterial AgentsCitric Acid CycleDrug CombinationsDrug SynergismFosfomycinHumansMercaptopurineMicrobial Sensitivity TestsPentose Phosphate PathwayStaphylococcus aureusVancomycinVancomycin ResistanceAnti-Bacterial AgentsDrug CombinationsFosfomycinMercaptopurineVancomycinmetabolismphysiologyStaphylococcus aureusvancomycin resistance

Identifiers

PMID29109158
PMCPMC5740343
OpenAlexW2766644912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.